Understanding how a new protein helps maintain gut health and reduce inflammation
Defining a novel transcriptional regulator of intestinal health and inflammation
This study is looking at a new protein that helps control how our immune system works in the gut, which could lead to better ways to manage conditions like inflammatory bowel disease (IBD) and keep our intestines healthy.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Weill Medical Coll of Cornell Univ NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11009050 on NIH RePORTER |
What this research studies
This research investigates a newly identified transcription factor that plays a crucial role in regulating immune responses in the intestine. By studying how this protein affects various immune and stromal cells, the research aims to uncover mechanisms that promote intestinal health and prevent inflammation. Patients may benefit from insights into how to better manage conditions like inflammatory bowel disease (IBD) through improved understanding of immune regulation. The approach includes laboratory experiments and analysis of immune cell behavior in the gut.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals suffering from inflammatory bowel disease or other gastrointestinal inflammatory conditions.
Not a fit: Patients with non-inflammatory gastrointestinal disorders or those without any gastrointestinal issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preventing and treating inflammatory bowel diseases and other related conditions.
How similar studies have performed: Other research has shown promising results in understanding immune regulation in the gut, suggesting that this approach could lead to significant advancements in treatment.
Where this research is happening
New York, United States
- Weill Medical Coll of Cornell Univ — New York, United States (Active)
Researchers
- Principal investigator: Zhou, Wenqing — Weill Medical Coll of Cornell Univ
- Study coordinator: Zhou, Wenqing
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.